Among patients with heart failure and reduced ejection fraction (HFrEF), those taking a "polypill" combination of three ...
Ingelheim, Germany, 3rd September, 2012 – New phase II data presented for the first time today at the 2012 European Respiratory Society (ERS) congress show that combining tiotropium with olodaterol ...
A phase three clinical trial that UT Southwestern participated in determined that a three-drug combination improved lung function and reduced symptoms in cystic fibrosis (CF) patients who have a ...
A single-inhaler triple therapy improved lung function in adults and adolescents with inadequately controlled asthma and was ...
Oral contraceptives combined with metformin are associated with improvements in health-related quality-of-life measures.
COYA 303 is an investigational biologic combination of COYA 301, Coya’s low-dose interleukin 2 (LD IL-2) and a GLP-1 receptor agonist (GLP-1RA), designed to deliver a multi-targeted immunomodulatory ...
Interim Data from Phase 2 Combination Study of VX-809 and KALYDECO™ (ivacaftor) Showed Significant Improvements in Lung Function (FEV1) in People with Cystic Fibrosis Who Have Two Copies of the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback